Loading verified market, valuation, and statement data.
2. Company Fundamentals
2.1 Competitiveness
| Metric |
Value |
| Free Float |
23.23B |
| Short Int % Utilisation |
1.29% |
2.2 Growth
| Metric |
Value |
| EV/EBITDA |
29.00 |
2.3 Management
| Role |
Metric |
| Consensus Rating |
N/A |
2.4 Return
| Metric |
Value |
| Expected Return (Ann.)* |
33.92% |
| Risk / Std Dev (Ann.)* |
36.88% |
| 1-Year Price Return* |
24.94% |
Latest Market Data (as of 2026-08-14, US Eastern time):
| Metric |
Value |
| Last Price |
$225.16 |
| 52-Week Range |
$164.07 – $236.54 |
| Observation Count |
251 trading days |
The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.
2.5 FCFF DCF Valuation
Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.
Step 1 — Forecast Operating Profit and NOPAT
| Reported operating input |
Value |
| Revenue |
$215.94B |
| Prior annual revenue |
$130.50B |
| EBIT |
$141.71B |
| Tax rate |
15.12% |
| NOPAT = EBIT × (1 − tax rate) |
$120.29B |
| Forecast start-growth basis |
15.00% |
| Forecast policy |
latest reported annual revenue growth, bounded to -10.00% / 15.00% |
Step 2 — Calculate FCFF
| Current FCFF building block |
Value |
| NOPAT |
$120.29B |
| Add: depreciation & amortisation |
$2.84B |
| Less: capital expenditure |
-$6.04B |
| Less/(add): working-capital cash-flow movement |
-$15.95B |
| Current unlevered FCFF |
$101.14B |
Explicit FCFF forecast
| Forecast year |
Revenue growth |
NOPAT |
D&A |
Capex |
Change in NWC |
FCFF |
Present value |
| 1 |
15.00% |
$138.33B |
$3.27B |
-$6.95B |
-$18.34B |
$116.31B |
$107.59B |
| 2 |
11.88% |
$154.76B |
$3.66B |
-$6.74B |
-$20.52B |
$131.15B |
$103.81B |
| 3 |
8.75% |
$168.30B |
$3.98B |
-$6.22B |
-$22.31B |
$143.74B |
$97.36B |
| 4 |
5.62% |
$177.76B |
$4.20B |
-$5.38B |
-$23.57B |
$153.01B |
$88.68B |
| 5 |
2.50% |
$182.21B |
$4.31B |
-$4.31B |
-$24.16B |
$158.05B |
$78.38B |
Step 3 — Determine the Discount Rate (WACC)
| WACC input |
Value |
| Risk-free rate |
4.71% |
| Equity risk premium assumption |
5.50% |
| Beta |
2.21 |
| Cost of equity |
16.89% |
| Pre-tax cost of debt |
2.46% |
| WACC |
16.86% |
| WACC validation |
requires assumption review |
Step 4 — Estimate Terminal Value
| Terminal-value input |
Value |
| Perpetuity growth rate |
2.50% |
| Terminal value |
$1,127.83B |
| Implied terminal EV / EBITDA |
5.15x |
| Terminal value as % of enterprise value |
52.09% |
Step 5 — Discount Cash Flows to Enterprise Value
| Enterprise-value component |
Value |
| Present value of explicit FCFF |
$475.83B |
| Present value of terminal value |
$517.42B |
| Indicated enterprise value |
$993.25B |
| Discounting convention |
mid-year for explicit FCFF; terminal value discounted at year-end five |
Step 6 — Convert Enterprise Value to Equity Value
| Equity bridge |
Value |
| Indicated enterprise value |
$993.25B |
| Less: gross interest-bearing debt |
$11.04B |
| Add: cash and equivalents |
$62.56B |
| Add: affiliate investments |
$0.00 |
| Less: minority interests |
$0.00 |
| Indicated common equity value |
$1,044.77B |
Step 7 — Calculate Indicative Value Per Share
| Per-share output |
Value |
| Shares used |
24,514,000,000.00 |
| Share-count basis |
reported diluted weighted-average shares |
| Current market price |
$220.41 |
| DCF indicative value per share |
$42.62 |
| Indicative value vs. market price |
-80.66% |
Model Integrity Checks
| Check |
Result |
| Perpetuity growth is below the risk-free rate |
pass |
| Perpetuity growth is below WACC |
pass |
| WACC is within the configured operating-company range |
review required |
| Terminal-year FCFF is positive |
pass |
| Terminal capex converges to D&A |
pass |
| Terminal-value concentration |
within review band |
| Implied price differs from spot by more than 30% |
review required |
2.6 Investor-Style Research Screen
| Educational screen |
Result |
| Buffett-inspired cash-quality checks |
3/4 evidenced checks |
| Lynch-inspired balance-and-growth checks |
4/4 evidenced checks |